Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
URL: https://www.biospace.com/news/
Updated: 1 year 18 weeks ago

FDA Flags Safety Risks of Compounded Versions of Novo’s Semaglutide, Reports Hospitalizations

Mon, 07/29/2024 - 02:00

AbbVie’s Skyrizi Wins EU Nod for Ulcerative Colitis, Helps to Weather Humira Patent Cliff

Mon, 07/29/2024 - 02:00

Merck’s Keytruda in Combo With Padcev Granted CHMP Positive Opinion in Urothelial Carcinoma

Mon, 07/29/2024 - 02:00

FDA Approves New Oral Alzheimer’s Therapy, Expands Label for Grifols’ SCIg Therapy

Mon, 07/29/2024 - 02:00

EU Regulatory Panel Recommends Against Approval of Eisai, Biogen’s Leqembi for Alzheimer’s

Fri, 07/26/2024 - 02:00
The European Medicines Agency’s Committee for Medicinal Products for Human Use found that Leqembi’s benefits do not outweigh the risks of severe side effects associated with the treatment.

Big Pharma Appears to Be Unfazed by IRA Drug Price Negotiations

Fri, 07/26/2024 - 02:00

BMS Gets Q2 Beat, Raises Full-Year Guidance as Cost-Cutting Initiative Continues

Fri, 07/26/2024 - 02:00

Roche to Accelerate Development of Obesity Assets from $2.7B Carmot Buy

Fri, 07/26/2024 - 02:00

FDA Adcomm Calls for Changes in Perioperative Lung Cancer Trials

Fri, 07/26/2024 - 02:00

Despite Near 30% Drop in Humira Sales, AbbVie Beats Wall Street’s Q2 Revenue Expectations

Thu, 07/25/2024 - 02:00
While Humira sales were impacted by cheaper biosimilars, AbbVie reported in its second-quarter earnings results Thursday that revenues jumped nearly 45% for Skyrizi and almost 56% for Rinvoq year over year, respectively.

AstraZeneca, Roche, Sanofi Raise 2024 Outlooks on Strong Q2 Sales

Thu, 07/25/2024 - 02:00

Viking Takes Obesity Candidate into Phase III to Rival Lilly, Novo

Thu, 07/25/2024 - 02:00

Novartis, Dren Bio Ink Potential $3B Deal for Anti-Myeloid Bispecific Antibodies for Cancer

Thu, 07/25/2024 - 02:00

FDA Issues Final Guidance for Using Real-World Data in Drug Applications

Thu, 07/25/2024 - 02:00

Majority Considering Jobs Outside Biopharma, BioSpace Report Finds

Thu, 07/25/2024 - 02:00

GSK’s Dovato Matches Efficacy of Gilead’s Biktarvy in Head-to-Head HIV Trial

Tue, 07/23/2024 - 02:00
In the largest study of its kind, GSK’s two-drug regimen Dovato demonstrated non-inferior efficacy compared to Gilead Sciences’ three-drug regimen Biktarvy for the treatment of HIV-1.

Merck Challenges AstraZeneca, Sanofi With Phase IIb/III Data for RSV Antibody

Tue, 07/23/2024 - 02:00

Agilent Pays $925M to Buy CDMO Biovectra to Boost Biologics, CRISPR Capabilities

Tue, 07/23/2024 - 02:00

SEC Hits Allarity With Wells Notice, Flags Alleged Violations in FDA Meeting

Tue, 07/23/2024 - 02:00

HHS Issues Negative Opinion on Bluebird’s Fertility Support Program for Gene Therapies

Tue, 07/23/2024 - 02:00